Prednisone for Back Pain: Not Recommended
Prednisone is not recommended for musculoskeletal back pain, as the highest quality evidence shows no benefit and potentially increased harm. 1
Evidence Against Prednisone for Back Pain
The most recent and highest quality study directly addressing this question found that prednisone 50 mg daily for 5 days provided no benefit for emergency department patients with acute musculoskeletal low back pain from bending or twisting injuries. 1 Specifically:
- No difference in pain scores at 5-day follow-up between prednisone and placebo groups (absolute difference 0.2 on 0-3 scale, 95% CI -0.2 to 0.6) 1
- No improvement in functional outcomes, including resuming normal activities, returning to work, or days lost from work 1
- More patients sought additional medical treatment in the prednisone group (40%) compared to placebo (18%), suggesting inadequate symptom control 1
Why This Matters: Significant Risks Without Benefit
Even short courses of prednisone carry meaningful risks that are not justified when there is no demonstrated benefit:
Bone Health Concerns
- Any dose ≥2.5 mg/day for ≥3 months requires calcium (1,000-1,200 mg/day) and vitamin D (600-800 IU/day) supplementation to prevent glucocorticoid-induced osteoporosis 2, 3
- Even low-dose prednisone (5 mg/day) significantly suppresses bone formation markers and may decrease bone resorption in postmenopausal women 4
- Fracture risk increases even at low doses and within the first month of treatment 3
High-Dose Risks
- Doses >30 mg/day are associated with significant mortality, particularly in elderly patients 2
- Very high-dose therapy (≥30 mg/day for ≥30 days or cumulative dose >5 grams over 1 year) dramatically increases fracture risk 2, 5
Appropriate Prednisone Use: When It IS Indicated
Prednisone has clear evidence-based indications for inflammatory conditions, not mechanical back pain:
Polymyalgia Rheumatica (PMR)
- Initial dose: 12.5-25 mg daily prednisone equivalent 6
- Lower doses (12.5 mg) preferred in patients with diabetes, osteoporosis, or glaucoma 6
- Strongly recommended against initial doses >30 mg/day 6
- Taper to 10 mg/day within 4-8 weeks, then by 1 mg every 4 weeks 6
Autoimmune Conditions
- Autoimmune hepatitis: 60 mg daily (monotherapy) or 30 mg daily with azathioprine 2
- Severe inflammatory disease: 1-2 mg/kg/day (maximum 60 mg/day) 5
Critical Safety Monitoring for Any Prednisone Use
If prednisone is prescribed for a legitimate indication (not back pain):
Mandatory Supplementation
- Calcium 1,000-1,200 mg/day and vitamin D 600-800 IU/day for any dose ≥2.5 mg/day for ≥3 months 2, 7
- Consider bisphosphonates for patients with low bone mineral density 7
Baseline Assessment
- Bone mineral density testing at baseline and annually for long-term therapy 2
- Fracture risk assessment using FRAX (for patients ≥40 years) with glucocorticoid dose adjustment 6
Tapering Protocol
- Never stop abruptly after long-term use 7
- Reduce by one-third to one-quarter until reaching 15 mg/day, then by 2.5 mg increments to 10 mg/day, then by 1 mg monthly 2
- Adrenal suppression risk occurs with any dose >7.5 mg/day for >3 weeks 5
Common Pitfalls to Avoid
- Do not prescribe prednisone for mechanical/musculoskeletal back pain – there is no evidence of benefit and clear evidence of harm 1
- Do not use doses >30 mg/day without compelling indication, as mortality risk increases significantly 2
- Do not neglect osteoporosis prevention even with short courses or low doses 2, 3, 4
- Do not forget stress-dose coverage during illness or surgery for patients on chronic steroids (>7.5 mg/day for >3 weeks) 5, 7